Peer Review History

Original SubmissionSeptember 27, 2020
Decision Letter - Danielle Poole, Editor

PONE-D-20-30425

Levels of Mother-to-Child HIV Transmission Knowledge and Associated Factors among Reproductive-Age Women in Ethiopia: Analysis of 2016 Ethiopian Demographic and Health Survey Data

PLOS ONE

Dear Dr. Gebre,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript has been evaluated by two reviewers, and their comments are available below. You will see the reviewers have commented on the strengths of your manuscript. However, they have also raised a number of concerns that should be addressed before the manuscript can be further considered for publication.

The key concerns noted by the reviewers relate to the description of the study context and the study instruments. Specifically, the reviewers requested clarity regarding the validity of the questionnaire items and scoring procedures in Ethiopia. 

Reviewer 2 has recommended that you cite specific previously published works. As always, we recommend that you please review and evaluate the requested works to determine whether they are relevant and should be cited. It is not a requirement to cite these works. 

Please note that while this manuscript should present new findings, novelty is not a requirement for publication in PLOS ONE: https://journals.plos.org/plosone/s/editorial-and-peer-review-process

Please submit your revised manuscript by May 15 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Danielle Poole

Staff Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. For more information on PLOS ONE's expectations for statistical reporting, please see https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting. Please update your Methods and Results sections accordingly.

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Overall comment: This is a well written paper with clear results backed by the data. While we understand that the data will be helpful for Ethiopia as a country, the topic in question has studied quite extensively and not much new evidence has been generated. The author will also need to review a few grammatical errors throughout the paper. The discussion of the paper needs some review - it has several statements that are just opinions without backing of literature.

Specific comments:

1. Background: Since this paper focus on PMTCT in Ethiopia, there has been minimal information provided in the background about the PMTCT program in Ethiopia to give context to the reader

2. Background: The administrative set-up of Ethiopia is not highlighted in the background. It is only in the Materials and Methods section that the reader is informed of the study covering the 9 regions and 2 two city administrations in Ethiopia. A sentence or so in the background on the administrative set-up of the country will help the reader contextualize the study coverage.

3. Materials and Methods: Can the author talks briefly about the validation of the questions used to assess clients knowledge in this study. Though used in Tanzania, have these been validated as good measures for MTCT knowledge? Also the categorization of the scoring - has that been validated as well?

4. Discussion: Line 289-292: The author says "The difference might be explained by the differences in the integration of HIV-related education in the maternal health care services in different geographical locations and differences in uptake of maternal health care services among the reproductive-age women residing in the different regions". However, these differences in the integration of HIV related education are not categorically stated and discussed. How are the differences? Do we have literature to demonstrate those differences.

5. Discussion: Line 300-301: The author says: "On the other hand, urban-resident women might have better access to education than rural-residents, which might boost their knowledge of MTCT of HIV". Do we have literature to support this statement?

6. Discussion: Line 321-324: The author says: "This could be explained by the inequalities in accessing educational services, health care services, and social media between women from rich households and those from poor households which might have significant impacts on MTCT of HIV-related knowledge among the women". It will be good to quote the literature to support that there are indeed inequalities between the rich and poor households.

Reviewer #2: Authors wrote an interesting and large paper (15.000 patients) on importatn issue from low income countries. Research from low setting are always important and I suggest to accept the paper on this minor revisions

1. Introduction: update data on burden of HIV globally and in your country. Child with HIV trasmission ogf HIV are defined "children at risk" to worste clincal and social outcome. Please add this concept, see and cite (The At Risk Child Clinic (ARCC): 3 Years of Health Activities in Support of the Most Vulnerable Children in Beira, Mozambique. )

2. Methods and results: are clear and well wrote

3. Discussion: discuss on the nedd of provision of HIV integrated services and compare with other data from Africa (see and citeCapacity assessment for provision of quality sexual reproductive health and HIV-integrated services in Karamoja, Uganda. Afr Health Sci. 2020). Furthermore, on mother and child trasmission give some public health proposal as in other experiece (Pathways of care for HIV infected children in Beira, Mozambique: pre-post intervention study to assess impact of task shifting. BMC Public Health. )

Conclusion: are coherent

References: ref 24 in in Japanese ?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr Caspian Chouraya

Reviewer #2: Yes: Francesco Di Gennaro

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

PONE-D-20-30425

Levels of Mother-to-Child HIV Transmission Knowledge and Associated Factors among Reproductive-Age Women in Ethiopia: Analysis of 2016 Ethiopian Demographic and Health Survey Data

PLOS ONE

Authors’ response: We are immensely grateful to both the reviewers and the editorial team for their invaluable constructive comments which helped us a lot to revise our manuscript.

A point-by-point response to reviewers’ comments

Reviewer #1: Overall comment: This is a well written paper with clear results backed by the data. While we understand that the data will be helpful for Ethiopia as a country, the topic in question has studied quite extensively and not much new evidence has been generated. The author will also need to review a few grammatical errors throughout the paper. The discussion of the paper needs some review - it has several statements that are just opinions without backing of literature.

# Response: We have extensively edited the grammar and revised the discussion

Specific comments:

1. Background: Since this paper focus on PMTCT in Ethiopia, there has been minimal information provided in the background about the PMTCT program in Ethiopia to give context to the reader

#Response: Now we have provided detailed account of information on PMTCT provision in Ethiopia on the page 3, line 113-121 of the manuscript.

2. Background: The administrative set-up of Ethiopia is not highlighted in the background. It is only in the Materials and Methods section that the reader is informed of the study covering the 9 regions and 2 two city administrations in Ethiopia. A sentence or so in the background on the administrative set-up of the country will help the reader contextualize the study coverage.

#Response: Now we have provided a highlight information about Ethiopia in the background of the manuscript on page 4, line 133-140

3. Materials and Methods: Can the author talks briefly about the validation of the questions used to assess clients knowledge in this study. Though used in Tanzania, have these been validated as good measures for MTCT knowledge? Also the categorization of the scoring - has that been validated as well?

#Response: In the current study we used the 2016 EDHS data. For collecting the EDHS data, standard protocols and three types of tools; the Household Questionnaire, the Woman’s Questionnaire, and the Man’s Questionnaire were used. Further contextualization and standardization of the questionnaires were also done by governmental and non-governmental shareholders to maintain the validity of the tools. We have described this in the method part of the manuscript on page 5, line 154-157. We used the study done in Tanzania as an additional reference for the logical operationalization of the women’s knowledge of the mother-to-child transmission of HIV.

4. Discussion: Line 289-292: The author says "The difference might be explained by the differences in the integration of HIV-related education in the maternal health care services in different geographical locations and differences in uptake of maternal health care services among the reproductive-age women residing in the different regions". However, these differences in the integration of HIV related education are not categorically stated and discussed. How are the differences? Do we have literature to demonstrate those differences.

#Response: we have edited this as “The difference might be explained by the differences in uptake of maternal health care services among the reproductive-age women residing in the different regions,” and supported the implication with literature on page 11, line 331-339.

5. Discussion: Line 300-301: The author says: "On the other hand, urban-resident women might have better access to education than rural-residents, which might boost their knowledge of MTCT of HIV". Do we have literature to support this statement?

#Response: we have revised this as “This might be because urban-resident women might have better access to maternal health care services and mass media than rural-resident women,” and supported the implication with literature on 11, line 345-349.

6. Discussion: Line 321-324: The author says: "This could be explained by the inequalities in accessing educational services, health care services, and social media between women from rich households and those from poor households which might have significant impacts on MTCT of HIV-related knowledge among the women". It will be good to quote the literature to support that there are indeed inequalities between the rich and poor households.

#Response: We have quoted literature for the implication on page 12, line 378-384.

Reviewer #2:

1. Introduction: update data on burden of HIV globally and in your country. Child with HIV trasmission ogf HIV are defined "children at risk" to worste clincal and social outcome. Please add this concept, see and cite (The At Risk Child Clinic (ARCC): 3 Years of Health Activities in Support of the Most Vulnerable Children in Beira, Mozambique. )

#Response: we have updated the information on the burden of the HIV from the global perspective to the study area on page 1, line 61-70. We have also included a statement about a “child at risk” in a context of this study and quoted references for it.

2. Discussion: discuss on the nedd of provision of HIV integrated services and compare with other data from Africa (see and citeCapacity assessment for provision of quality sexual reproductive health and HIV-integrated services in Karamoja, Uganda. Afr Health Sci. 2020). Furthermore, on mother and child trasmission give some public health proposal as in other experiece (Pathways of care for HIV infected children in Beira, Mozambique: pre-post intervention study to assess impact of task shifting. BMC Public Health.)

#Response: In the current study, we have not categorically studied the provision of the HIV integrated services; therefore, we could not compare our findings with the findings from the reference suggested. The study done in Mozambique titled with “Pathways of care for HIV infected children in Beira, Mozambique: pre-post intervention study to assess impact of task shifting,” was to evaluate the effectiveness of task-shifting (TS) from clinical officers to maternal and child nurses to improve care for HIV positive children < 5 years old. The study concluded that the task-shifting was effective in caring for HIV positive children. However, the findings of the study were not related to the women’s knowledge of the MTCT of the HIV infection. Therefore, we did not used it as a reference.

References: ref 24 in in Japanese ?

#Response: Since we have added another references in the background parts of the manuscript, the sequential order of the reference 24 became reference 36. it is an editorial error; we have corrected it.

Attachments
Attachment
Submitted filename: Response to reviewers.docx
Decision Letter - Avanti Dey, Editor

Levels of Mother-to-Child HIV Transmission Knowledge and Associated Factors among Reproductive-Age Women in Ethiopia: Analysis of 2016 Ethiopian Demographic and Health Survey Data

PONE-D-20-30425R1

Dear Dr. Gebre,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Avanti Dey, PhD

Staff Editor

PLOS ONE

Additional Editor Comments (optional):

This manuscript is now ready for acceptance. One minor point has been raised by Reviewer #1, so please ensure that HAART  is replaced with ART throughout the manuscript.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The comments have been adequately addressed. However, please note that HAART is now a redundant term and rarely used. Please replace with ART throughout the manuscript

Reviewer #2: cogratulations. I think the paper can be now accept. The paper is interesting and also the setting of research

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr Caspian Chouraya

Reviewer #2: No

Formally Accepted
Acceptance Letter - Avanti Dey, Editor

PONE-D-20-30425R1

Levels of Mother-to-Child HIV Transmission Knowledge and Associated Factors among Reproductive-Age Women in Ethiopia: Analysis of 2016 Ethiopian Demographic and Health Survey Data

Dear Dr. Gebre:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Avanti Dey

Staff Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .